http://www.clinicaltrials.gov/ct2/show/NCT01476826?term=recell&rank=3
This phase 2 trial is expected to be completed in december 2012.
The Page was Lasted updated in october so looks like it is running on time.
I believe this will have a serious affect on the share price and could be our next catalyst.
a feasibility study of the recell® autologous
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.84 |
Change
-0.120(3.03%) |
Mkt cap ! $268.3M | |||
| Open | High | Low | Value | Volume |
| $3.94 | $3.94 | $3.76 | $511.0K | 134.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $3.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.84 | 11883 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| AVH (ASX) Chart |